First clinical trials of novel drug for aggressive leukemia treatment

Blood oncological disease (leukemia) called non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are extremely aggressive and resistant to any treatment. Against these, several chemotherapy treatment types are used being more or less effective. But at the same time, patients rapidly develop treatment resistance and unexpected adverse events of intoxication. A novel drug voiding these adverse events has been successfully clinically studied in patients.

Advanced anti- Alzheimer disease drug close to finish clinical trials

The number of people suffering from neurodegenerative diseases such as Alzheimer's disease is constantly growing all over the world, which forces scientists to constantly search for drugs to effectively treat such conditions. However, despite the fact that there are already a number of drugs against Alzheimer's disease, their clinical use is often complicated by the adverse events. Promising drug Verubecestat is on the latest trials at the Merck Research Laboratory in New Jersey, which could be a rescue for Alzheimer's patients.